FUSEN PHARM

01652
0.69012.66% ( -0.100 )
Delay Closed: Nov 20, 16:08:00

Valuation

Current ValuationThe current P/E ratio is -190.81, below the reasonable range, cheaper than 95.48% of the time in the past 5 years, and the industry ranks 52/54, the industry Median 7.34.

-190.81xP/E
Stock priceHK$0.69Earnings per shareHK$-0.00

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 7.34x
09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 7.34x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
06887HKSUNSHINE PHARMA
-63.55x--HK$20.85B
02630HKVIGONVITA-B
-34.47x--HK$12.10B
09637HKALEBUND-B
-8.71x48.51%HK$7.06B
00570HKTRAD CHI MED
-4.70x223.71%HK$5.46B
02575HKXUANZHUBIO-B
-16.06x--HK$3.88B
01477HKOCUMENSION-B
-25.70x52.42%HK$3.71B
09941HKSINOTAUPHARMA-B
----HK$3.41B
02552HKHUA MEDICINE-B
-17.16x104.78%HK$2.13B
01349HKFUDANZHANGJIANG
-17.69x--HK$2.12B
02652HKCF PHARMTECH
-232.95x--HK$1.82B
06622HKZHAOKE OPHTH-B
-4.06x--HK$1.00B
01652HKFUSEN PHARM
-190.81x--HK$510.12M
01011HKNT PHARMA
-14.15x--HK$449.14M
01643HKMODERN CHI MED
-5.60x--HK$270.00M
08329HKNEP INTERLONG
-3.20x--HK$194.65M
00575HKREGENT PACIFIC
-12.30x--HK$188.22M
00858HKEXTRAWELL PHAR
-0.17x--HK$168.20M
01312HKKONTA CHINA
-0.79x--HK$167.66M
00455HKTIANDA PHARMA
-2.15x--HK$148.35M
01498HKPURAPHARM
-4.55x--HK$125.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.